Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

Ana Botin, executive chair of Spanish bank Santander has denied reports that the company is considering leaving the British ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Ken Hall looks at three important considerations for investors looking to build a sizeable passive income for a better financial future.

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

PURCHASE, NY. — Rachel Ferdinando has been promoted from president of PepsiCo Foods Canada to chief executive officer of ...

BV100 is a new formulation of rifabutin suitable for intravenous administration, which BioVersys claims offers a new ...

Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...